Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05163600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary and study completion dates: Dec 31, 2025 to Dec 31, 2026Primary endpoints: 1 to 4 · Interventions: Blod flow restriction training (Other) to BFR REsistance 48% vs. 80% LOP (Other), BFR Resistance 80% LOP (Other), BFR-CYC 3x2min (Other), BFR-CYC 50% peak / 50% AOP (exhaustive)… · Secondary endpoints expanded, about 110 words · 3 morev6Show 6 more changesShow less
Primary endpoints: 1 to 4
Interventions: Blod flow restriction training (Other) to BFR REsistance 48% vs. 80% LOP (Other), BFR Resistance 80% LOP (Other), BFR-CYC 3x2min (Other), BFR-CYC 50% peak / 50% AOP (exhaustive)…
NotableTrial status: Not Yet Recruiting to RecruitingStudy sites: 0 to 1 · Start date changed from estimate of Mar 1, 2022 to May 20, 2022v4Show 2 more changesShow less
Study sites: 0 to 1
Start date changed from estimate of Mar 1, 2022 to May 20, 2022
NotableStart date: Jan 1, 2022 to Mar 1, 2022v3
MinorRe-verified, no change to tracked fieldsv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that BFR exercise regimens result in a different acute cardiorespiratory response pattern compared to traditional exercise regimens. Furthermore, the investigators hypothesize that these patterns differ between healthy participants and participants with COPD.
Regarding secondary objective, the investigators hypothesize that BFR results in lower blood pressure responses compared to traditional exercise training in both healthy and COPD participants.